October 26th and 27th ...
The invitation only conference has invited over 58 of the leading stem cell companies, including 39 from the U.S., seven from Australia, three from Israel and twelve others internationally, to present in front of hundreds of Wall Street institutional investors in the first "stem-cell-only" conference of its kind.
PSTI doesn't need anyone to pump. The tech is unique in the entire world and its success is a matter of time. The company cannot control what it cannot control. Producing a product that will be approved all over the world takes time even with the advanced pathway that recently opened up and which yield faster inclusion.
This message board doesn't impact the share price. Global approval will impact it and the significant achievements to that to happen will begin to be seen in the coming new year.
If you don't like Allo, put him/her on ignore. The idea of paid pumpers is for trash-spam-scam stocks....NOT PSTI.
I exchanged 2 emails with Ari, the CFO and encouraged others to make their dissatisfaction and frustration known. Did anyone or was I the sole complainer?
Not another brilliant, meaningful, predictive discovery!!! I wish I could take their unique technological and scientific brilliance to the bank. I could really use a few bucks about now.
As I said on this board before, CTSO's products should have been approved YESTERDAY everywhere that it still is not. A shame on these bureaucratic agencies who cannot afford to drag their feet but don't seem to know it.
That's the problem. No one will buy no matter how impressive the science until they've struck some deals and/or a therapeutic product is born.
It all depends on your time horizon. When I first bought in, the business model they were pursuing was different and, had it succeeded, would have provided rewards in a year or two at most. But as things morphed, gradually enough that I didn't perceive the change for what it was, the horizon line moved further and further. If you have a long time horizon, this is a good investment. Wasn't what I came aboard for, but there you have it and here I am.
Pluristem Completed Successful Meeting With the U.S. FDA in Preparation for Filing an IND for PLX-R18 to Treat Incomplete Hematopoietic Recovery After Bone Marrow Transplantation
My comings and goings had nothing to do with manipulations or strategies. Why would I "inform" anyone they could "lose their bids" or gain? I don't know. I'm not anyone's financial consultant or guru. I live in the M.E. but am not a prophet. When the price went down, I didn't disappear. I did post from time to time that I was disappointed but that, in the long term, I thought the company would execute. I was waiting and saw no need to get into any fierce debates or controversies here. I still think the company will execute and will not repeat it day in and day out.
All the more the call the FDA guilty of negligence that it takes even 30 days and that approval is not yesterday. People pass away while they consider their protocols.